Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?
Détails
Etat: Public
Version: Author's accepted manuscript
ID Serval
serval:BIB_B81E79A4FF80
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?
Périodique
Neuro-oncology
ISSN
1523-5866 (Electronic)
ISSN-L
1522-8517
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
17
Numéro
11
Pages
1425-1427
Langue
anglais
Notes
Publication types: Editorial
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Antineoplastic Agents/therapeutic use, Brain Neoplasms/drug therapy, Brain Neoplasms/genetics, DNA Methylation/genetics, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Dacarbazine/analogs & derivatives, Dacarbazine/therapeutic use, Glioblastoma/drug therapy, Glioblastoma/genetics, Humans, Promoter Regions, Genetic/genetics, Tumor Suppressor Proteins/genetics
Pubmed
Web of science
Open Access
Oui
Création de la notice
22/12/2015 17:42
Dernière modification de la notice
20/08/2019 15:26
Données d'usage
